-
91.发明公开
公开(公告)号：EP1809300A4
公开(公告)日：2009-03-25
申请号：EP05802065
申请日：2005-09-26
Applicant: IDEXX LAB INC
Inventor： MURTHY YERRAMILLI V S N
IPC: A61K31/20 , A61K31/706 , A61P31/04
CPC classification number: A61K31/706 , A61K31/20
-
公开(公告)号：EP2724130A4
公开(公告)日：2015-07-08
申请号：EP12789422
申请日：2012-05-23
Applicant: IDEXX LAB INC
Inventor： MISENER GARLAND CHRISTIAN , MILAN JAMES EDWARD , LACHAPELLE ROBERT W
CPC classification number: G01J3/4406 , G01J3/28 , G01N21/64 , G01N2021/6417 , G01N2201/124
-
公开(公告)号：EP2715353A4
公开(公告)日：2014-12-17
申请号：EP12792727
申请日：2012-05-31
Applicant: IDEXX LAB INC
Inventor： YERRAMILLI MURTHY V S N , YERRAMILLI MAHALAKSHMI , ATKINSON MICHAEL
IPC: G01N33/74
CPC classification number: G01N33/54306 , G01N33/74 , G01N2333/58 , G01N2800/32
-
公开(公告)号：EP1991200A4
公开(公告)日：2013-01-16
申请号：EP07749662
申请日：2007-02-01
Applicant: IDEXX LAB INC
Inventor： MURTHY YERRAMILLI V S N
IPC: A61K9/08 , A61K31/4709 , A61K31/496 , A61K47/02 , A61K47/10 , A61K47/12 , A61K47/40 , A61K47/48
CPC classification number: A61K31/4709 , A61K9/0019 , A61K9/0095 , A61K9/08 , A61K31/496 , A61K47/02 , A61K47/10 , A61K47/12 , A61K47/40
Abstract: The invention relates to pharmaceutical compositions comprising (i) a fluoroquinolone, (ii) a salt formed between a carboxylate anion and a divalent metal cation, (iii) a liquid comprising an organic solvent selected from the group consisting of glycerol, propylene glycol, glycerol formal, and (iv) optionally water. The invention further relates to methods of treating or preventing a condition in an animal comprising administering to the animal in need thereof a pharmaceutical composition of the invention.
-
95.发明公开PHOSPHOLIPID GEL COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF TREATING CONDITIONS USING SAME 有权磷脂凝胶组合物用于疾病治疗的药品供应和方法
公开(公告)号：EP1781256A4
公开(公告)日：2012-05-09
申请号：EP05766244
申请日：2005-06-23
Applicant: IDEXX LAB INC
Inventor： MURTHY YERRAMILLI V S N
IPC: A61K47/24 , A61K9/00 , A61K9/06 , A61K9/127 , A61K31/137 , A61K31/573 , A61K31/7036 , A61K31/704
CPC classification number: A61K9/06 , A61K9/0017 , A61K9/0046 , A61K9/0048 , A61K31/137 , A61K31/573 , A61K31/7036 , A61K47/24
-
Patent Agency Ranking
公开(公告)号：EP1954398A4
公开(公告)日：2011-10-19
申请号：EP06825348
申请日：2006-10-03
Applicant: IDEXX LAB INC
Inventor： RICH CARL RUSSELL
CPC classification number: B01L3/5021 , B01L2200/026 , B01L2200/087 , B01L2200/143 , B01L2300/0681 , B04B5/0407 , B04B7/08 , B04B11/043
-
97.发明公开PHOSPHOLIPID GEL COMPOSITIONS FOR DELIVERY OF APTAMERS AND METHODS OF TREATING CONDITIONS USING SAME 有权PHOSPHOLIPIDGELZUSAMMENSETZUNGEN为苦难使用的治疗有管理的适体和方法
公开(公告)号：EP1960415A4
公开(公告)日：2011-09-21
申请号：EP06836943
申请日：2006-11-03
Applicant: IDEXX LAB INC
Inventor： MURTHY YERRAMILLI V S N
CPC classification number: A61K9/06 , A61K31/685 , A61K31/7088 , A61K47/24 , A61K2300/00
-
公开(公告)号：EP2091649A4
公开(公告)日：2011-06-29
申请号：EP07867477
申请日：2007-11-16
Applicant: IDEXX LAB INC
Inventor： PELLETIER DOMINIC , PHELPS JEFFREY , AGUIAR JASON , HAMMOND JEREMY , TRAIGLE WILLIAM J , SINNETT CHANDLER G
IPC: B01L3/02
CPC classification number: B01L3/0275 , B01L3/0262 , B01L2200/141 , B01L2400/025
-
99.发明公开
公开(公告)号：EP2164948A4
公开(公告)日：2010-12-08
申请号：EP08768409
申请日：2008-06-12
Applicant: IDEXX LAB INC
Inventor： ELSEMORE DAVID ALLEN , FLYNN LAURIE A
IPC: C12M1/34 , G01N33/569
CPC classification number: G01N33/5308
-
100.发明公开METAL CHELATES AND METHODS OF USING THEM FOR TIME-RESOLVED FLUORESCENCE 审中-公开金属螯合物和应用˚FRZEITAUFGEL STE荧光法
公开(公告)号：EP1556323A4
公开(公告)日：2006-06-21
申请号：EP03779170
申请日：2003-10-23
Applicant: IDEXX LAB INC
Inventor： MURTHY YERRAMILLI , SUVA ROBERT H
IPC: C07C45/45 , C07C49/788 , C07C49/813 , C07C49/84 , C07C49/92 , C07C51/44 , C07C225/22 , C07C255/56 , C07D213/50 , C07F9/53 , C07C49/115 , A61K31/74 , B01J10/00 , G01N33/543
CPC classification number: C07C49/84 , C07C45/455 , C07C49/788 , C07C49/813 , C07C49/92 , C07C51/44 , C07C225/22 , C07C255/56 , C07D213/50 , C07F9/5345 , C07C57/04
Abstract: β-diketone fluorescent tags are disclosed, particularly those enabling the use of excitation energy in the near visible or visible spectrum. In some cases, these tags allow the use of cost-effective excitation devices such as LED’s. The compounds form fluorescent chelates (complexes) with lanthanide (III) rare earth metal ions (such as EU3+). The fluorescent complex may be included in a latex microparticle, such as a styrene latex particle. Ideally, the complex has an absorption maximum λ equal to or greater than 360 nm, and the compound is characterized by a pKa
-
-
-
-
-
-
-
-
-
Search Results
791
records
(took 0.026 seconds)
